Training on GLP-1: How to Exercise on Ozempic, Wegovy or Mounjaro and Keep Your Muscle

Should you exercise while taking a GLP-1 medication?

Yes — and not mainly to lose more weight. The medication already does most of that. In STEP 1, adults taking semaglutide 2.4 mg lost 14.9% of their body weight over 68 weeks, against 2.4% on placebo. What the drug does not do is choose which tissue that weight comes from, keep you strong, or keep the weight off once you stop. Those are the jobs exercise is for.

The four medical and nutrition societies behind the 2025 joint advisory on GLP-1 therapy put it on the same list: alongside managing gastrointestinal side effects and preventing nutrient deficiencies, they name preserving muscle and bone mass through resistance training and appropriate diet as a core priority, and recommend assessing muscle strength, function and body composition before treatment starts.

How much of the weight you lose on a GLP-1 is muscle?

It varies more than headlines suggest. Neeland and colleagues reviewed the trial data and found lean-mass reductions ranging from 40–60% of total weight lost in some studies to roughly 15% or less in others. Differences in population, drug and measurement explain much of that spread. For comparison, the old rule of thumb for ordinary dieting is that about one quarter of the weight lost is fat-free mass — a rule Heymsfield's review showed is itself an average with wide scatter.

Two caveats stop this from being as alarming as it sounds:

• Lean mass is not muscle. DXA "lean mass" also counts organs, bone, fluid and the water inside fat tissue. When you lose a lot of fat, some of that goes too.
• Muscle quality may improve. MRI-based studies in the same review suggest the loss of muscle volume on GLP-1 therapy is roughly what you would expect for the weight lost, while fat infiltration inside the muscle falls.

The review is equally clear on the other side: older age and more severe disease raise the risk of sarcopenia, and that is where deliberately protecting muscle matters most. If you want the nutrition side of that in detail, see how to prevent muscle loss on GLP-1.

What does exercise add on top of the medication?

The best evidence comes from a Copenhagen trial that tested exercise and a GLP-1 drug head to head. Lundgren and colleagues put 195 adults with obesity on an eight-week low-calorie diet (average loss 13.1 kg), then randomised them for a year to exercise, liraglutide 3.0 mg, both, or placebo.

The combination cut body-fat percentage by about twice as much as either treatment alone, and only the combination improved HbA1c, insulin sensitivity and cardiorespiratory fitness. The weight difference between the combination and liraglutide alone was not statistically significant — the scale barely told the two apart; the body-composition scan did.

The follow-up is the part that matters most for anyone who expects to stop treatment one day. One year after all treatment ended, people who had done the combination weighed 5.1 kg less and had 2.3 percentage points less body fat than those who had taken liraglutide alone, and weight regain after stopping liraglutide was 6.0 kg larger than after stopping the exercise programme. Exercise was the part of the treatment that kept working. For what typically happens after stopping, see Ozempic rebound weight gain.

Resistance training or cardio: which matters more on a GLP-1?

For protecting muscle, resistance training. There is no large GLP-1 trial comparing exercise types yet, so the clearest data comes from dieting without medication. Villareal and colleagues randomised 160 older adults with obesity to a weight-loss programme plus aerobic, resistance or combined training. Body weight fell about 9% in every exercise group, but what was lost differed:

Resistance training protected lean mass and built strength; aerobic training built fitness; the combination got most of both and produced the biggest improvement in physical function. That is the template worth copying on a GLP-1: lift for the muscle, move for the heart.

How much exercise do you need on a GLP-1?

The WHO baseline for adults applies unchanged: 150–300 minutes of moderate aerobic activity a week (or 75–150 minutes vigorous), plus muscle-strengthening activity for all major muscle groups on two or more days a week. A practical week looks like this:

1. Two or three full-body strength sessions — a squat or leg press, a hinge (deadlift, hip thrust), a push, a pull and a carry. Aim to add a rep or a little load most weeks; progression is the signal.
2. Walking or easy cardio on most days — 20–40 minutes at a pace where you can still talk. It counts towards the 150 minutes and is gentle on a queasy stomach.
3. One harder aerobic session if you enjoy it — optional, and the first thing to drop in a bad side-effect week.

If you are starting from nothing, start with one strength session and daily walks and build over a month. Consistency across months beats intensity in week one.

How do you train when nausea and low appetite get in the way?

Gastrointestinal effects are the most common side effect: in STEP 1, nausea and diarrhoea led the list, were usually mild to moderate and faded over time, and 4.5% of participants stopped semaglutide because of them. Training around them is mostly scheduling:

• Learn your pattern first. Many people feel worst a day or two after the injection or after a dose increase. Put strength sessions on your better days and walks on the rest. The week-by-week side-effect timeline shows what to expect when.
• Eat small, not nothing. Training on an empty stomach while barely eating is how sessions end in dizziness. A small, low-fat snack with some protein an hour or two before usually sits better than a meal.
• Drink before you are thirsty. Eating less food means taking in less water with it, and vomiting or diarrhoea make that worse.
• Lower the intensity, keep the habit. On a rough day, a shorter session at lighter loads keeps the routine alive without making the nausea worse.
• Ask about blood sugar if you take other diabetes medication. Exercise lowers blood glucose, and insulin or sulfonylureas raise the risk of hypoglycaemia during and after it. Your prescriber can tell you how to adjust.

How do you fuel training when you are barely hungry?

Protein first. The International Society of Sports Nutrition's position stand puts the daily range for exercising adults at 1.4–2.0 g of protein per kg of body weight, spread over the day in servings of roughly 20–40 g, with a serving before or after training as a sensible anchor. On a GLP-1 that is genuinely hard to hit, because protein is filling and appetite is low — which is why dense sources such as Greek yoghurt, eggs, fish and protein shakes matter (ranked in the best protein sources for GLP-1 users). If your weight or kidney function makes the right target unclear, a registered dietitian can set it with you.

What to track so you know the weight you lose is fat

The scale cannot tell fat from muscle, and on a GLP-1 it will go down almost regardless of what you do. Track the things that can tell them apart:

• Your strength log. If the weights you lift hold steady or rise while the scale falls, you are overwhelmingly losing fat. Falling strength over several weeks is the early warning.
• Daily protein against your target. The week you miss it is usually the week strength stalls.
• Weekly weight trend and waist. Waist falling at the same rate as weight is a good sign; a trend smooths out water swings.
• Side effects next to training days. After a few weeks you will see which days you can train hard and which call for a walk.
• Resting heart rate. GLP-1 drugs can raise it — in the Copenhagen trial, increased heart rate was reported more often with liraglutide alone than with liraglutide plus exercise — so a baseline is worth having.

This is what tr8ck's GLP-1 muscle-loss tracking is built around: doses and side effects in the GLP-1 module, strength sessions in the exercise module, and protein, weight and resting heart rate on the same timeline — so you can see whether the weight coming off is the weight you wanted to lose.

FAQ

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs; do not start, stop or change your dose without your prescriber. If you have heart disease, diabetes treated with insulin or sulfonylureas, kidney disease, or are returning to exercise after a long break, speak to a qualified healthcare professional before starting a new training programme.